Preclinical exploration of Kidney Diseases
Full range of in vitro and in vivo preclinical services to unravel the benefits of your molecules with certainty.
Why choose NEPHRIX Biosolution ?
- Exclusive expertise in Kidney and Fibrotic diseases
- Predictive, reproducible, and translational models
- Fast study initiation and adaptable study designs
- High-quality histology and quantitative digital pathology
- Ethical and 3Rs commitment
- Trusted by renowned Pharma, Biotech and Academic partners
Featured Models

In vitro Assays using human primary fibroblasts from different origins (renal, lung, cardiac or skin).

Determining the potential toxicity of a drug candidate or preventing the tissue damage by therapeutic interventions.

Validated surgical and ethical procedures on mice and rats to induce acute and chronic diseases.
Read more...

Robust in vitro Senescence Assay platform using human primary cells from various tissue origins.

Diabetic models to explore the pathology mechanisms including fibrosis, inflammation and glomerular alterations.

Bioanalysis platform to assess therapeutic’s efficacy, safety, and mechanism of action during the drug development process.
Strategic Partners





Contact
NEPHRIX Biosolutions
516, rue Pierre et Marie Curie31670 Labège - FRANCE
Tel +33 6 81 44 55 35
Mail: contact[at]nephrix-biosolutions.com